Jalyn and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Jalyn (dutasteride; tamsulosin hydrochloride), especially for people who are male, 60+ old, also take Revlimid, and have Multiple myeloma.

The study is created by eHealthMe based on reports of 1,123 people who have side effects when taking Jalyn from the FDA, and is updated regularly.

What is Jalyn?

Jalyn has active ingredients of dutasteride; tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 1,168 Jalyn users. Check the latest studies of Jalyn.

On Apr, 13, 2026

1,123 people reported to have side effects when taking Jalyn.
Among them, 17 people (1.51%) died.

Among these 17 people:

What is the gender of people who died when taking Jalyn? *

female: 0.0 %
male: 100 %

What is the age of people who died when taking Jalyn? *

What are other drugs people take besides Jalyn? *

What are other side effects people have before they died? *

General Physical Health Deterioration (weak health status): 2 people, 11.76%
Pneumonia: 1 person, 5.88%
Fatigue (feeling of tiredness): 1 person, 5.88%
Dyspnea (difficult or laboured breathing): 1 person, 5.88%
Decreased Activity: 1 person, 5.88%
Cardiac Failure: 1 person, 5.88%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 29.41%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 5.88%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%
Prostatomegaly (enlargement of the prostate): 1 person, 5.88%
Parkinson's Disease: 1 person, 5.88%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jalyn:

Jalyn (1,168 reports)

Expand to all the drugs that have ingredients of dutasteride; tamsulosin hydrochloride:

Death and drugs with ingredients of dutasteride; tamsulosin hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Jalyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,163 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dutasteride; tamsulosin hydrochloride (the active ingredients of Jalyn) and Jalyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.